AstraZeneca PLC, Celgene Corp. and Novo Nordisk A/S were among drugmakers who adjusted either revenue or earnings forecasts for 2017 after the third quarter.
Guidance for the largest pharmaceutical and biotechnology companies by market value are listed below.
![]() |

